CORDIS Project
Funding breakdown and partner intelligence are Premium
Sign in and upgrade to Premium for EU contribution totals, consortium analytics, OpenAlex research context, and AI summaries. · 0 consortium intelligence fields visible of 1
Start free • Cancel anytime • 14-day refund guarantee
This project combines photoredox catalysis with bioconjugation to target a specific biomarker associated with various diseases. By using visible light to facilitate chemical reactions, it aims to improve the identification of this biomarker, potentially aiding in early disease diagnosis.
Photoredox catalysis (the use of visible-light to accelerate chemical reactions) has emerged as a uniquely valuable platform in organic chemistry, facilitating the use of native functionality to construct new C–C bonds.
The key aim of this research is the unification of photoredox catalysis and bioconjugation to specifically target 3-nitrotyrosine (3NT) – a critical biomarker for the diagnosis of several diseases including Alzheimer's, heart disease, and stroke, in order to facilitate the rapid…
Partner organizations (coordinator is shown above), with normalized type and CORDIS activity type. Guests see up to 4 partners.
United States, Princeton, Nj
Type: University / higher education
Activity type: Higher or Secondary Education Establishments
SME: No
Similar projects, consortium collaboration history, frequent partners, and OpenAlex research context.
Guests see up to 5 EuroSciVoc fields.
Guests see up to 5 topics.
